HOME >> BIOLOGY >> NEWS
New Columbia Genomic Center of Excellence aims to speed genetic targeting of medicines

WHAT: A journalist briefing on the new Columbia University Center of Excellence in Genomic Science, which was recently designated and funded at $11 million by the National Human Genome Research Institute (NHGRI). The project is among the first to be funded by the NHGRI since the completion of the human genome project.

The new center will build on discoveries at Columbia University and Columbia University Health Sciences that have led to speedier processes of DNA sequencing. Center scientists hope to advance techniques that will increase the accuracy and dramatically reduce the cost of individual genome sequencing. The hope is that this more efficient process will lead to the ability to better identify genetic susceptibilities to disease and develop more effective, individualized genetically targeted treatments for a range of diseases. Neuronal diversity and plasticity will be a primary focus.

WHEN: Thursday, October 16, 2003, 12:00 1:00 p.m.

The briefing will take place during "Genes and Genomes: Impact on Medicine and Society," a far-ranging and unique symposium that brings together internationally known researchers across various disciplines to explore the answers genetic research is providing, as well the questions it is raising for the practice of medicine and for society. Journalists are welcome to attend the two-day symposium, which is part of Columbia University's 250th anniversary celebration.

WHO: Gerald D. Fischbach, MD, Executive Vice President and Dean, Faculty of Medicine, Columbia University Health Sciences
Eric Kandel, MD, University Professor at Columbia University and Winner of the 2000 Nobel Prize in Physiology or Medicine
Jiangyue Ju, Ph.D., Associate Professor of Chemical Engineering and Head of DNA Sequencing & Chemical Biology, Columbia Genome Center
Conrad Gilliam, Ph.D., Professor of Genetics and Development and Director, Columbia Genome Center

WHER
'"/>

Contact: Dennis Tartaglia
dennist@mbooth.com
212-481-7000
M Booth & Associates
14-Oct-2003


Page: 1 2

Related biology news :

1. Columbia research to examine gene influence on severity of peridontal disease, therapy response
2. Columbia, Stony Brook, Guidant to develop biological pacemaker based on gene & cell therapies
3. Worlds largest scientific society holds regional meeting in Columbia, Mo.
4. Columbia offers new ecology program in Dominican Republic
5. Columbia professor receives 2003 National Golden Apple for Teaching Excellence
6. Columbia investigators win 2003 Gairdner International Award for research
7. Gene newly identified by Columbia researchers may improve hair removal
8. Years of research, thought lead geologist to propose new supercontinent Columbia
9. Columbia team finds treatment that corrects cellular defect at the root of heart failure
10. ESA Corporate Award winner 2001: Weyerhaeuser Company Limited British Columbia Coastal Forest Project Team
11. Columbia receives NYSTAR grant - Brain imaging studies will accelerate medical science and create jobs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: